Equifax Inc.
NYSE:EFXConsulting Services
-$0.93 today
- Market cap
- $21.02B
- Beta
- 1.31
- P/E (TTM)
- 26.4
- EPS (TTM)
- $5.82
- Dividend yield
- 1.38%
Volume 1.13M
Average 1.76M
EFX Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Equifax Inc.NYSE: EFX
Accounts Receivables · Q3 FY2026 · quarter ended Sep 2026
Accounts receivables turns negative
Q3 FY2026 accounts receivables was -$500K, compared with $23.4M a year earlier. Trailing-twelve-month accounts receivables was -$87M. Over 3 fiscal years it compounded at -33.4% a year.
Context
- Accounts receivables amounted to 0.7% of revenue in FY2025, down 0.5 pp from a year earlier.
- Accounts receivables grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly accounts receivables holds near -$500K or moves back toward the trailing-twelve-month quarterly average of -$21.75M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (40.9M) USD
- Year-over-year change
- +38.3%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (40.9M) | +38.3% |
| FY2024 | 2024-12-31 | (66.3M) | -184.5% |
| FY2023 | 2023-12-31 | (23.3M) | +83.2% |
| FY2022 | 2022-12-31 | (138.6M) | -109.4% |
| FY2021 | 2021-12-31 | (66.2M) | — |
Accounts Receivables vs competitors
How EFX compares with its peers on the latest reported figures
- EFX's LTM Sep 2026 accounts receivables of $87M is the 6th largest of the 10 companies compared; the peer median is $2.16M.
- Its year-over-year change of +35.7% is the 6th highest of 10, against a peer median of +68.6%.
- Accounts receivables amounts to 1.3% of revenue for EFX, versus a peer median of 1.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $217.74M | +156.0% | -42.8% | 5.5% | |
| LTM Jun 2026 | $191.2M | +232.3% | -71.8% | 6.1% | |
| LTM Aug 2026 | $165.4M | +68.6% | -2.7% | 2.5% | |
| LTM Jun 2026 | $165.4M | +24.6% | +47.1% | 3.4% | |
| LTM Sep 2026 | $107M | +1139.7% | — | 1.0% | |
| LTM Sep 2026 | $87M | +35.7% | -33.4% | 1.3% | |
| LTM Jun 2026 | $9M | +103.1% | — | 0.1% | |
| LTM Jun 2026 | $2.58M | -103.3% | — | 0.0% | |
| LTM Mar 2026 | $2.16M | -92.8% | +3.7% | 0.1% | |
| LTM Mar 2026 | $2.14M | -74.8% | -27.7% | 0.5% | |
| Peer median (excluding EFX) | $2.16M | +68.6% | -15.2% | 1.0% | |
Competitors are the stored peer set for EFX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 748.5M | 700.2M | 551.7M | 607.3M | 664.3M |
| Depreciation & Amortization | 489.6M | 568.6M | 619.8M | 680.6M | 726.9M |
| Deferred Income Tax | 9.3M | 88.1M | (70.2M) | (66.9M) | 30.2M |
| Stock-Based Compensation | 54.9M | 62.6M | 71.8M | 81.6M | 78.4M |
| Change in Working Capital | (26.3M) | (625.6M) | (42.5M) | 21.9M | 117.1M |
| Accounts Receivables | (66.2M) | (138.6M) | (23.3M) | (66.3M) | (40.9M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 39.9M | (487M) | (19.2M) | 88.2M | 158M |
| Other Non-Cash Items | 58.8M | (36.8M) | (13.8M) | 0 | (1.2M) |
| Operating Cash Flow | 1.33B | 757.1M | 1.12B | 1.32B | 1.62B |
| Capital Expenditures | (469M) | (624.5M) | (601.3M) | (511.5M) | (481.4M) |
| Acquisitions (Net) | (2.93B) | (335M) | (276.9M) | 0 | (74.1M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | (1.2M) |
| Other Investing Activities | 4.9M | 0 | 0 | 0 | 2.4M |
| Investing Cash Flow | (3.4B) | (959.5M) | (878.2M) | (511.5M) | (554.3M) |
| Debt Repayment | 920.3M | 491.5M | (77.6M) | (704.6M) | 76.2M |
| Common Stock Issued | 46.8M | 16.9M | 32.3M | 78.2M | 46.4M |
| Common Stock Repurchased | (69.9M) | 0 | 0 | 0 | (927.5M) |
| Dividends Paid | (190M) | (191.1M) | (191.8M) | (193.2M) | (232.8M) |
| Other Financing Activities | (89.5M) | (43.6M) | (69.1M) | (26.8M) | (22M) |
| Financing Cash Flow | 617.7M | 273.7M | (306.2M) | (846.4M) | (1.06B) |
| Effect of Forex Changes | (14.2M) | (10.8M) | (800K) | (13.5M) | 9.2M |
| Net Change in Cash | (1.46B) | 60.5M | (68.4M) | (46.9M) | 10.9M |
| Free Cash Flow | 865.8M | 132.6M | 515.5M | 813M | 1.13B |
Equifax Inc.
NYSE:EFX
Intrinsic Alpha fair value
Locked
Current Price
$179.66
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.